# Agilent Technologies, Inc. (A) FY2024 Annual P&L / Income Statement - Company: Agilent Technologies, Inc. (A) - Period: 2023-11-01 to 2024-10-31 - Filing: FY2024 10-K, filed 2024-12-20, accession number 0001090872-24-000049 - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement - Chart image: https://plicit.ai/charts/a-fy2024-annual-income-statement-sankey.png ## Chart details: Revenue by Product and Service Income statement for 2023-11-01 through 2024-10-31. View: Product and service (Revenue by Type). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **Instrumentation**: 2,354,000,000 US dollars - **Non-Instrumentation and Other**: 4,156,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement/revenue-by-geography - Chart image: https://plicit.ai/charts/a-fy2024-annual-revenue-by-geography-sankey.png Income statement for 2023-11-01 through 2024-10-31. View: Geography (Entity-Wide Disclosures Revenue). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **UNITED STATES**: 2,246,000,000 US dollars - **CHINA**: 1,217,000,000 US dollars - **Rest Of World**: 3,047,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement/revenue-by-business-segment - Chart image: https://plicit.ai/charts/a-fy2024-annual-revenue-by-business-segment-sankey.png Income statement for 2023-11-01 through 2024-10-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **Life Sciences and Applied Markets**: 3,215,000,000 US dollars - **Diagnostics and Genomics**: 1,651,000,000 US dollars - **Agilent CrossLab**: 1,644,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars - **Life Sciences and Applied Markets costs (calculated)**: 2,338,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Diagnostics and Genomics costs (calculated)**: 1,331,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Agilent CrossLab costs (calculated)**: 1,120,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. - **Reconciling items (calculated)**: 233,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses. ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Business Segment by Geography - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement/revenue-by-business-segment-by-geography - Chart image: https://plicit.ai/charts/a-fy2024-annual-revenue-by-business-segment-by-geography-sankey.png Income statement for 2023-11-01 through 2024-10-31. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **Agilent CrossLab - Americas**: 674,000,000 US dollars - **Agilent CrossLab - Asia Pacific**: 518,000,000 US dollars - **Agilent CrossLab - Europe**: 452,000,000 US dollars - **Diagnostics and Genomics - Americas**: 904,000,000 US dollars - **Diagnostics and Genomics - Asia Pacific**: 240,000,000 US dollars - **Diagnostics and Genomics - Europe**: 507,000,000 US dollars - **Life Sciences and Applied Markets - Americas**: 995,000,000 US dollars - **Life Sciences and Applied Markets - Asia Pacific**: 1,409,000,000 US dollars - **Life Sciences and Applied Markets - Europe**: 811,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Product and Service (2) - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement/revenue-by-product-and-service-2 - Chart image: https://plicit.ai/charts/a-fy2024-annual-revenue-by-product-and-service-2-sankey.png Income statement for 2023-11-01 through 2024-10-31. View: Product and service. Revenue and costs use their disclosed categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **Products revenue**: 4,672,000,000 US dollars - **Services and Other revenue**: 1,838,000,000 US dollars - **Products cost of revenue**: 2,024,000,000 US dollars - **Services and Other cost of revenue**: 951,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by End Markets - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement/revenue-by-end-markets - Chart image: https://plicit.ai/charts/a-fy2024-annual-revenue-by-end-markets-sankey.png Income statement for 2023-11-01 through 2024-10-31. View: End Markets. Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **Pharmaceutical and Biopharmaceutical Market**: 2,242,000,000 US dollars - **Chemical and Advanced Materials Market**: 1,495,000,000 US dollars - **Diagnostics and Clinical Market**: 964,000,000 US dollars - **Food Market**: 592,000,000 US dollars - **Academia and Government Market**: 567,000,000 US dollars - **Environmental and Forensics Market**: 650,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income. ## Chart details: Revenue by Geography (2) - Page: https://plicit.ai/financials/a/fy2024-annual-income-statement/revenue-by-geography-2 - Chart image: https://plicit.ai/charts/a-fy2024-annual-revenue-by-geography-2-sankey.png Income statement for 2023-11-01 through 2024-10-31. View: Geography (Revenue by Region). Revenue uses this breakdown; costs and expenses retain the consolidated categories. - **Net revenue**: 6,510,000,000 US dollars - **Cost of revenue**: 2,975,000,000 US dollars - **Gross profit (calculated)**: 3,535,000,000 US dollars - **Operating expenses (calculated)**: 2,047,000,000 US dollars - **Income from operations**: 1,488,000,000 US dollars - **Other income (expense), net (calculated)**: 33,000,000 US dollars - **Income before taxes, as reported**: 1,521,000,000 US dollars - **Provision for income taxes**: 232,000,000 US dollars - **Net Income**: 1,289,000,000 US dollars - **Americas**: 2,573,000,000 US dollars - **Europe**: 1,770,000,000 US dollars - **Asia Pacific**: 2,167,000,000 US dollars - **Research and development**: 479,000,000 US dollars - **Selling, general and administrative**: 1,568,000,000 US dollars ### Chart connections - Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income. - Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.